Sergliflozin etabonate
Sergliflozin etabonate, a SGLT-2 inhibitor, is used potentially for the treatment of type 2 diabetes and obesity.
Product Specifications
CAS Number
408504-26-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
448.468
Molecular Formula
C23H28O9
Notes
Research use only, not for human use.
Receptor
Protoporphyrinogen oxidase
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15081561 1 Vial
Lentiviral human TRAFD1 shRNA (UAS) - Lentiviral human TRAFD1 shRNA (UAS, GFP) (100)
Ask
View Details 